Article

Does Organized Care Benefit All Stroke Patients?

New research shows stroke patients benefit from organized care no matter the stroke etiology.

In regards to new research that shows stroke patients benefit from organized care no matter the stroke etiology, lead author Eric Smith, University of Calgary, Alberta, Canada, said “Here, we show in a real-world setting that increasing level of organized stroke care is strongly associated with decreased mortality in each of the main ischemic stroke subtypes.” For the study, organized care consisted of occupational therapy or physiotherapy, stroke team assessment, and treatment on a stroke unit.

In patients with lacunar stroke, mortality risk was reduced by 84%, in cardioembolic stroke by 63%, in large-artery atherosclerotic stroke by 57%, and in other/undetermined stroke by 80% if participants had an organized care index grade of 2-3 as opposed to 0-1.

"Our data suggest that all ischemic stroke subtypes benefit from organized care, including mild lacunar strokes and severe cardioembolic strokes," concluded the researchers.

More Recent Stroke News:

  • Combined Antiplatelet Prophylaxis Fails to Impact Stroke Severity
  • Stroke Rife in Urban Sub-Saharan Africa
  • TCD Findings Could Aid TIA Risk Stratification
Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.